Neuroone Medical Technologies vs Inspiremd
Neuroone Medical Technologies and Inspiremd are similar in size: $9.1m and $9.0m of revenue in their latest fiscal years. Neuroone Medical Technologies grew faster (163.5% against 28.1%). Neuroone Medical Technologies kept more of each dollar of sales as profit: a net margin of -39.6% against -543.3%.
| Latest fiscal year | Neuroone Medical TechnologiesNMTC, 2025 | InspiremdNSPR, 2025 |
|---|---|---|
| Revenue | $9.1m | $9.0m |
| Revenue growth | 163.5% | 28.1% |
| Net income | −$3.6m | −$48.8m |
| Operating margin | — | -552.6% |
| Net margin | -39.6% | -543.3% |
| Return on equity | -91.3% | -106.9% |
| Free cash flow | −$2.9m | −$36.8m |
| Cash | $6.6m | $8.9m |
| Total debt | $0 | $0 |
| Debt to equity | — | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 18 | 127 |
| Market value | $8.2m | $29.7m |
| Price vs our value range | — | — |
| Moat score | 21 (Weak) | 18 (Weak) |
| Insider trades, 12 months | 2 buys, 6 sales | 18 buys, 12 sales |